The US Food and Drug Administration (FDA) has approved Pfizer and BioNTech’s mRNA COVID-19 vaccine, Comirnaty, for people 16 years or older. The announcement represents not just the first approved ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet ...
The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...
The COVID pandemic feels like a long time ago. Now, we have widespread immunity from vaccination and natural infection. And ...
French pharmaceutical company Sanofi has filed lawsuits against Pfizer and Moderna, claiming the companies used patented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results